Glaxosmithkline Company Timeline (GSK)

WINNERS & LOSERS: Miners slide; Centrica to pay GBP20 million to Ofgem

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

GSK agrees China hepatitis B deal as kicks off last tranche of buyback

(Alliance News) - GSK PLC on Monday launched the fifth tranche of its GBP2.0 billion buyback as it announced an exclusive collaboration with China pharmaceutical group Sino Biopharmaceutical Ltd.

GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme

(Sharecast News) - Drugmaker GSK said on Monday that it has struck an exclusive agreement with Sino Biopharmaceutical subsidiary Chia Tai Tianqing Pharmaceutical to accelerate its chronic hepatitis B...

LONDON BRIEFING: Compass lifts outlook as GSK expands in China

(Alliance News) - Compass Group raised annual profit guidance after reporting double-digit first-half operating profit growth, while GSK announced a China partnership for hepatitis B treatment bepirov...

UK dividends calendar - next 7 days

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

LONDON BROKER RATINGS: Citi cuts United Utilities and Severn Trent

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

European shares hit three-week low as earnings, data and Iran conflict weigh

* Earnings mixed. Healthcare stocks drag, Adidas outperforming

LONDON MARKET CLOSE: Stocks wilt as oil soars ahead of likely Fed hold

(Alliance News) - The FTSE 100 closed lower on Wednesday, held back by falls in drugs firms GSK and AstraZeneca, while oil surged amid reports that the US is eyeing a longer blockade of the Strait of...

GSK shares slide as investors question one-off result boost

* Stock top ⁠decliner on the FTSE 100

UK shareholder meetings calendar - next 7 days

Sales jump at GSK on strong demand for specialty drugs

(Sharecast News) - GSK posted above-forecast first-quarter profits on Wednesday, boosted by robust demand for its specialist HIV and oncology drugs.

LONDON BRIEFING: AstraZeneca, Lloyds, GSK post first-quarter growth

(Alliance News) - AstraZeneca, Lloyds Banking Group and GSK report higher earnings in the first quarter.

GSK beats quarterly profit estimates on strength in respiratory, general medicines

LONDON, April ​29 (Reuters) - ⁠British ​drugmaker GSK reported first-quarter ​profit ‌above ⁠analysts' expectations on Wednesday, ⁠helped ​by strong sales of its respiratory ​and ‌other general medici...

IN BRIEF: GSK given fast-track review by US FDA for hepatitis B drug

GSK PLC - London-based pharmaceuticals maker - Bepirovirsen, GSK's treatment for chronic hepatitis B, is accepted for priority review and given 'breakthrough therapy designation' by the US Food & Drug...

GSK hepatitis B drug secures FDA priority review

(Sharecast News) - Pharmaceutical giant GSK said on Tuesday that the US Food and Drug Administration had accepted its new drug application for bepirovirsen for priority review, with the drug being ass...

GSK's liver treatment efimosfermin makes US, EU regulatory progress

(Alliance News) - GSK PLC on Monday announced two positive regulatory rulings for efimosfermin, a once-monthly investigational liver therapy.

US court dismisses part of GSK subsidiary's licence dispute claim

(Alliance News) - GSK PLC on Monday said a US court has dismissed part of a legal claim involving its subsidiary Tesaro Inc.

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, while Harworth Group receives planning consent for...

US court rules against GSK in dispute with AnaptysBio

(Sharecast News) - A US court has granted a motion to dismiss filed by biotech AnaptysBio in a dispute with GSK's oncology unit, it was confirmed on Monday.

UK earnings, trading statements calendar - next 7 days

US military no longer required to get flu vaccine, Hegseth says

WASHINGTON, April 21 (Reuters) - The Pentagon ​will no longer ⁠require members of the ​U.S. military to get the flu vaccine, Defense Secretary Pete Hegseth said ​on ‌Tuesday.

European shares dip as US-Iran tensions weigh on sentiment

* Thales shares drop after Q1 sales miss analyst forecasts